Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
$676K Hold
12,457
2.11% 20
2015
Q1
$719K Hold
12,457
2.21% 19
2014
Q4
$666K Sell
12,457
-10,929
-47% -$611K 2.01% 22
2014
Q3
$1.34M Sell
23,386
-22,236
-49% -$1.36M 2.48% 11
2014
Q2
$3.05M Sell
45,622
-877
-2% -$59.4K 2.39% 11
2014
Q1
$3.11M Hold
46,499
2.6% 11
2013
Q4
$3.07M Sell
46,499
-114,950
-71% -$7.45M 2.39% 9
2013
Q3
$10.1M Buy
161,449
+63,874
+65% +$4.11M 1.75% 18
2013
Q2
$6.09M Buy
+97,575
New +$6.19M 1.03% 37

Other funds holding GSK

Investors Trust's GSK Position: Q2 2015 in Review

Investors Trust held its GSK (GSK) position steady in Q2 2015 at 12,457 shares worth $676K. The position accounts for 2.11% of the portfolio, ranked #20.

Investors Trust first reported a position in GSK in Q2 2013 and has held it in 9 quarters since. The position peaked at $10.1M in Q3 2013. 719 funds tracked by Wall St. Rank hold GSK as of Q2 2015.

  • Investors Trust held 12,457 shares of GSK worth $676K as of Q2 2015.
  • Investors Trust left its GSK share count unchanged in Q2 2015.
  • GSK made up 2.11% of Investors Trust's portfolio in Q2 2015, its #20 holding.
  • Investors Trust first reported a position in GSK in Q2 2013 and has held it in 9 quarters since.
  • Investors Trust's GSK position peaked at $10.1M in Q3 2013.
  • 719 funds tracked by Wall St. Rank held GSK as of Q2 2015.

Based on Investors Trust's 13F filing for Q2 2015, filed 14 Aug 2015.